New and Emerging Non-Opioid Treatment Strategies for Pain Management: An Update for Pharmacists | PTCE Pharmacy Connect
Educational Objectives
Describe the impact of COVID-19 on surgical pain management
Review current postoperative pain management guidelines and emerging non-opioid treatment approaches for pain management, including safety and efficacy data on newer treatments, and key considerations for pharmacists
Faculty:
Jawad N. Saleh, PharmD, BS, BCPS, BCCCP
Clinical Manager of Pharmacy Services
Pharmacy Department
The Hospital for Special Surgery
New York, New York
Faculty, has the following financial relationships with commercial interests to disclose:
Jawad N. Saleh, PharmD, BS, BCPS, BCCCP, has the following relevant financial relationships with commercial interests to disclose:
Consultant: Heron Therapeutics, Baudax Bio
Speakers Bureau: Heron Therapeutics, Baudax Bio
Scientific Advisory Boards: Heron Therapeutics, Baudax Bio
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.75 contact hour (0.075 CEU) under the ACPE universal activity number 0290-0000-22-046-H08-P. The activity is available for CE credit through February 24, 2023.
This activity is supported by an educational grant from Heron.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Describe the impact of COVID-19 on surgical pain management
Review current postoperative pain management guidelines and emerging non-opioid treatment approaches for pain management, including safety and efficacy data on newer treatments, and key considerations for pharmacists
Faculty:
Jawad N. Saleh, PharmD, BS, BCPS, BCCCP
Clinical Manager of Pharmacy Services
Pharmacy Department
The Hospital for Special Surgery
New York, New York
Faculty, has the following financial relationships with commercial interests to disclose:
Jawad N. Saleh, PharmD, BS, BCPS, BCCCP, has the following relevant financial relationships with commercial interests to disclose:
Consultant: Heron Therapeutics, Baudax Bio
Speakers Bureau: Heron Therapeutics, Baudax Bio
Scientific Advisory Boards: Heron Therapeutics, Baudax Bio
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.75 contact hour (0.075 CEU) under the ACPE universal activity number 0290-0000-22-046-H08-P. The activity is available for CE credit through February 24, 2023.
This activity is supported by an educational grant from Heron.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Activity